AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported a net loss, on an adjusted basis, for the first quarter of 2024 when its
Infographic: AngioDynamics reports adjusted loss for Q1 2024; sales down 4%
Categories
Medical Devices
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates
Earnings Summary: Here’s how CooperCompanies (COO) performed in Q3 2023
Medical device maker CooperCompanies (NYSE: COO) announced financial results for the third quarter of 2023, reporting an increase in revenues. Third-quarter revenue
Medtronic PLC Q1 2024 Earnings Conference Call Insights
Key highlights from Medtronic PLC (MDT) Q1 2024 Earnings Concall Management Update: [00:04:08] MDT is focusing its R&D investments on technology megatrends
Medtronic (MDT) Q1 2024 Earnings: Key financials and quarterly highlights
Medtronic plc (NYSE: MDT) reported first quarter 2024 earnings results today. Worldwide revenue was $7.7 billion, up 4.5% on a reported basis
Agilent Technologies Inc Q3 2023 Earnings Conference Call Insights
Key highlights from Agilent Technologies Inc (A) Q3 2023 Earnings Concall Management Update: [00:04:02] A said it now expects core growth for
Earnings: All you need to know about Agilent Technologies’ Q3 2023 results
Agilent Technologies (NYSE: A) on Tuesday reported mixed results for the third quarter of 2023 when the medical device company's adjusted earnings
Agilent Technologies Q3 2023 Earnings Call: Listen Live and Get the Real-Time Transcript
Medical device company Agilent Technologies, Inc. (NYSE: A) will be reporting financial results today evening, even as the earnings season reaches its
BSX Earnings: Highlights of Boston Scientific’s Q2 2023 results
Medical device maker Boston Scientific Corporation (NYSE: BSX) reported financial results for the second quarter of 2023. The company also provided guidance for
Earnings: Danaher Corporation (DHR) Q2 2023 sales and profit decline
Technology company Danaher Corporation (NYSE: DHR) reported lower sales and net profit for the second quarter of 2023. Second-quarter net income was $1.11
Intuitive Surgical (ISRG) reports higher Q2 revenues and earnings
Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) announced operating results for the second quarter of 2023, reporting higher revenues and adjusted
Earnings: AngioDynamics (ANGO) reports higher adj. profit for Q4; revenue up 5%
Medical device company AngioDynamics Inc. (NASDAQ: ANGO) on Wednesday reported an increase in adjusted profit for the fourth quarter of 2023, aided
Earnings Summary: CooperCompanies (COO) reports Q2 2023 financial results
Medical device maker CooperCompanies (NYSE: COO) has announced financial results for the second quarter of 2023, reporting lower earnings despite an increase
Infographic: How Medtronic (MDT) performed in Q4 2023
Medtronic plc (NYSE: MDT) reported fourth quarter 2023 earnings results today. Revenue was $8.5 billion, up 5.6% year-over-year, both on a reported
Agilent Technologies (A) Q2 2023 earnings, revenue increase
Agilent Technologies (NYSE: A) has announced second-quarter 2023 financial results, reporting an increase in adjusted profit and revenues. The Santa Clara, California-based
Boston Scientific Corp (BSX) Q1 2023 Earnings Call Transcript
Boston Scientific Corp (NYSE: BSX) Q1 2023 earnings call dated Apr. 26, 2023 Corporate Participants: Lauren Tengler -- Vice President, Investor Relations Michael F.
BSX Earnings: Highlights of Boston Scientific’s Q1 2023 results
Medical device maker Boston Scientific Corporation (NYSE: BSX) reported financial results for the first quarter of 2023. The company also provided guidance for
Infographic: How Thermo Fisher Scientific (TMO) performed in Q1 2023
Thermo Fisher Scientific Inc. (NYSE: TMO) reported first quarter 2023 earnings results today. Revenue was $10.71 billion, down 9% from the same
Everything you need to know about Biogen’s (BIIB) Q1 2023 earnings
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) reported lower earnings, on an adjusted basis, and revenues for the first quarter of 2023. Total
Earnings: Danaher Corporation (DHR) Q1 2023 sales and profit decline
Danaher Corporation (NYSE: DHR), a provider of industrial and medical products, reported lower sales and net profit for the first quarter of 2023. The
Intuitive Surgical (ISRG) looks poised for a strong year ahead
The healthcare industry has been witnessing an increase in demand for robotic-assisted surgical procedures due to their high efficiency and convenience. Intuitive